Relationship of cigarette smoking with inflammation and subclinical vascular disease: The multi-ethnic study of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 4, 2015, Pages 1002-1010

  McEvoy, John W ^a   Nasir, Khurram ^a,b   Defilippis, Andrew P ^a,c   Lima, Joao A C ^a   Bluemke, David A ^d   Hundley, W Gregory ^e   Barr, R Graham ^f   Budoff, Matthew J ^g   Szklo, Moyses ^a   Navas Acien, Ana ^a   Polak, Joseph F ^h   Blumenthal, Roger S ^a   Post, Wendy S ^a   Blaha, Michael J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MIAMI CANCER INSTITUTE   (United States)

^c University of Louisville School of Medicine   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; coronary artery disease; inflammation; smoking

Indexed keywords

C REACTIVE PROTEIN; COTININE; FIBRINOGEN; INTERLEUKIN 6; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGE; ANKLE BRACHIAL INDEX; AORTIC DISTENSIBILITY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY FLOW MEDIATED DILATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; SELF REPORT; SEX; SMOKING; SMOKING CESSATION; URINE LEVEL; VASCULAR DISEASE; VASODILATATION; ADVERSE EFFECTS; AGED; ANCESTRY GROUP; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; ETHNOLOGY; HEMODYNAMICS; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; PROTECTION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; UNITED STATES; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BIOMARKERS; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; COTININE; CROSS-SECTIONAL STUDIES; DIAGNOSTIC IMAGING; FEMALE; HEMODYNAMICS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; UNITED STATES;

EID: 84933533901     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304960     Document Type: Article

References (30)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014.
2. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation. 2014;129:399-410. doi: 10.1161/01.cir.0000442015.53336.12.
3. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731-1737. doi: 10.1016/j.jacc.2003.12.047.
4. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, Fiore MC, Stein JH. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol. 2010;55:1988-1995. doi: 10.1016/j.jacc.2010.03.002.
5. Grana R, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation. 2014;129:1972-1986. doi: 10.1161/CIRCULATIONAHA.114.007667.
6. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J; Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132-140. doi: 10.1016/S0140-6736(09)61717-7.
7. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17:2167-2176.
8. Danesh J, Lewington S, Thompson SG, et al; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant metaanalysis. JAMA. 2005;294:1799-1809. doi: 10.1001/jama.294.14.1799.
9. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
10. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78. doi: 10.1371/journal. pmed.0050078.
11. Sarwar N, Butterworth AS, Freitag DF, et al; IL6R Genetics Consortium Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205-1213. doi: 10.1016/S0140-6736(11)61931-4.
12. Reichert V, Xue X, Bartscherer D, Jacobsen D, Fardellone C, Folan P, Kohn N, Talwar A, Metz CN. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest. 2009;136:212-219. doi: 10.1378/chest.08-2288.
13. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765-1773. doi: 10.1093/eurheartj/ehi183.
14. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med. 2005;2:e160. doi: 10.1371/journal.pmed.0020160.
15. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88(5 pt 1):2149-2155.
16. Li H, Srinivasan SR, Berenson GS. Comparison of the measures of pulsatile arterial function between asymptomatic younger adult smokers and former smokers: The Bogalusa Heart Study. Am J Hypertens. 2006;19: 897-901. doi: 10.1016/j.amjhyper.2006.02.004.
17. Yu-Jie W, Hui-Liang L, Bing L, Lu Z, Zhi-Geng J. Impact of smoking and smoking cessation on arterial stiffness in healthy participants. Angiology. 2013;64:273-280. doi: 10.1177/0003319712447888.
18. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471-476.
19. Krishnan RM, Adar SD, Szpiro AA, Jorgensen NW, Van Hee VC, Barr RG, O'Neill MS, Herrington DM, Polak JF, Kaufman JD. Vascular responses to long-and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution). J Am Coll Cardiol. 2012;60:2158-2166. doi: 10.1016/j.jacc.2012.08.973.
20. Sharrett AR, Ding J, Criqui MH, Saad MF, Liu K, Polak JF, Folsom AR, Tsai MY, Burke GL, Szklo M. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: The Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2006;186:441-447. doi: 10.1016/j.atherosclerosis.2005.08.010.
21. Markus MR, Stritzke J, Baumeister SE, Siewert U, Baulmann J, Hannemann A, Schipf S, Meisinger C, Dörr M, Felix SB, Keil U, Völzke H, Hense HW, Schunkert H; MONICA/KORA Augsburg Cohort Study. Effects of smoking on arterial distensibility, central aortic pressures and left ventricular mass. Int J Cardiol. 2013;168:2593-2601. doi: 10.1016/j. ijcard.2013.03.045.
22. Richey Sharrett A, Coady SA, Folsom AR, Couper DJ, Heiss G; ARIC Study. Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease-The ARIC Study. Atherosclerosis. 2004;172:143-149.
23. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277-2283. doi: 10.1001/jama.290.17.2277.
24. Baldassarre D, Castelnuovo S, Frigerio B, Amato M, Werba JP, De Jong A, Ravani AL, Tremoli E, Sirtori CR. Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis. Stroke. 2009;40:1991-1998. doi: 10.1161/STROKEAHA.108.543413.
25. Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, Bild DE, Burke GL. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;115:2722-2730. doi: 10.1161/CIRCULATIONAHA.106.674143.
26. Rasmussen T, Frestad D, Køber L, Pedersen JH, Thomsen LH, Dirksen A, Kofoed KF. Development and progression of coronary artery calcification in long-term smokers: adverse effects of continued smoking. J Am Coll Cardiol. 2013;62:255-257. doi: 10.1016/j.jacc.2013.04.013.
27. Jöckel KH, Lehmann N, Jaeger BR, Moebus S, Möhlenkamp S, Schmermund A, Dragano N, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J, Erbel R. Smoking cessation and subclinical atherosclerosis-results from the Heinz Nixdorf Recall Study. Atherosclerosis. 2009;203:221-227. doi: 10.1016/j.atherosclerosis.2008.05.041.
28. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
29. Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, Jerosch-Herold M, Hundley WG, Lima JA, Bluemke DA. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: The Multiethnic Study of Atherosclerosis. J Am Coll Cardiol. 2006;48:2285-2292. doi: 10.1016/j. jacc.2006.03.072.
30. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation. 2009;120:502-509. doi: 10.1161/CIRCULATIONAHA.109.864801.